Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention Results of the GOLD (AU-assessing Ultegra) multicenter study - Steinhubl, SR; Talley, JD; Braden, GA (Circulation, 2001)
et al.